Review Article · Übersichtsarbeit
Transfusion Medicine in SwitzerlandLevy G.a · Byland C.b · Niederhauser C.b · Schwabe R.a · Senn M.c · Taleghani B.M.b
aExecutive Board of the Blood Transfusion Service SRC, bRegional Blood Transfusion Service Bern LTD, cSwissmedic (Haemovigilance), Berne, Switzerland
Do you have an account?
Swiss transfusion medicine currently encompasses 13 Regional Blood Transfusion Services (RBTS) under the Blood Transfusion Service of the Swiss Red Cross Ltd (BTS SRC) which is responsible for quality standards, logistics, and reference activities in immunohaematology and testing for infectious diseases, as well as haematological divisions of several university hospitals. Switzerland covers currently its own needs of labile blood components. According to the law, blood components are drugs and must comply with the actual legal requirements. Furthermore, the BTS SRC has published mandatory guidelines for all RBTS to ensure the standardisation of used methods. Haemovigilance is in charge of Swissmedic and covers all aspects of transfusion medicine, from donor selection to blood transfusion. Measures for preventing immunological and non-immunological risks as well as transfusion-transmitted diseases are also implemented at all stages of the process. The last preventive measures are universal pre-storage leucocyte depletion (in 1999), exclusion from blood donation of individuals who stayed longer than 6 months in the UK (in 2002) or have previously been transfused (in 2004). Mandatory screening of blood donations includes anti-HIV 1/2, HIV NAT, anti-HCV, HCV NAT, HBsAg, anti-Treponema pallidum and alaninaminotransferase. In the last years the calculated residual risk for transfusion-transmitted HIV or HCV was approximately 1:2-3 million and for HBV approximately 1: 200,000-300,000. Future challenges are the maintenance of self-sufficiency, the sustained recruitment of dedicated staff and the rising costs.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.